KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Current Leases (2016 - 2025)

Neogenomics (NEO) has disclosed Current Leases for 16 consecutive years, with $4.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Current Leases rose 41.26% year-over-year to $4.8 million, compared with a TTM value of $4.8 million through Dec 2025, up 41.26%, and an annual FY2025 reading of $4.8 million, up 41.26% over the prior year.
  • Current Leases was $4.8 million for Q4 2025 at Neogenomics, up from $4.5 million in the prior quarter.
  • Across five years, Current Leases topped out at $7.0 million in Q3 2021 and bottomed at $11000.0 in Q2 2023.
  • Average Current Leases over 5 years is $4.0 million, with a median of $4.5 million recorded in 2024.
  • The sharpest move saw Current Leases crashed 99.81% in 2023, then skyrocketed 32390.91% in 2024.
  • Year by year, Current Leases stood at $1.1 million in 2021, then skyrocketed by 480.09% to $6.6 million in 2022, then fell by 14.79% to $5.6 million in 2023, then plummeted by 39.73% to $3.4 million in 2024, then skyrocketed by 41.26% to $4.8 million in 2025.
  • Business Quant data shows Current Leases for NEO at $4.8 million in Q4 2025, $4.5 million in Q3 2025, and $4.1 million in Q2 2025.